Defining Anxious Depression: Going beyond Comorbidity

Abstract

French

Objective:

Since publication of the DSM-IV, there remains a group of patients with depression and anxiety symptoms who are not well classified. We therefore wanted to determine more accurately the type of patients best described by the term “anxious depression.” We also wanted to review the literature to assess the most appropriate treatment(s) for these patients.

Method:

We surveyed the medical literature published after 1994 for all articles containing the relevant terms and assessed all possible articles in detail to determine those relevant to the diagnosis and those that involved relevant clinical studies.

Results:

The term anxious depression can encompass 3 groups of patients: those with comorbid major depressive disorder (MDD) and an anxiety disorder, those with MDD but with subthreshold anxiety symptoms, and those with subthreshold depressive and subthreshold anxiety symptoms (also called mixed anxiety and depressive disorder).

Conclusions:

Based upon our literature review, we believe that the term anxious depression should only be used for the second group; that is, those patients with an MDD and subthreshold anxiety symptoms. From our literature review to determine the most appropriate treatment for this group of patients, it appears likely that drugs inhibiting the reuptake of both noradrenaline and serotonin may have greater clinical utility than single-action drugs such as the selective serotonin reuptake inhibitors (SSRIs). However, it is also clear that much more research needs to be undertaken in this important patient group so that we can better understand its prevalence, clinical features, and treatment.

Keywords

generalized anxiety disorder major depressive disorder review diagnosis treatment antidepressants comorbidity

References

Roth

Gurney

Kerr

. Studies in the classification of affective disorders: The relationship between anxiety states and depressive illness-I. Br J Psychiatry 1972;121:147–61.

Sartorius

Cross-cultural research on depression. Psychopathology 1986;19(suppl 2):6–11.

Posternak

Zimmerman

The prevalence of atypical features across mood, anxiety, and personality disorders. Compr Psychiatry 2002;43:253–62.

Roy-Byrne

Anxiety in primary care depression: How does it lead to poor outcomes and what can we do about it?

Gen Hosp Psychiatry 1999;21:151–3.

Keller

The long-term clinical course of generalized anxiety disorder. J Clin Psychiatry 2002;63(suppl 8):11–6.

Gorman

. Treatment of generalized anxiety disorder. J Clin Psychiatry 2002;63(suppl 8):17–23.

Sheehan

. Attaining remission in generalized anxiety disorder: Venlafaxine extended release comparative data. J Clin Psychiatry 2001:62(Suppl 19):26–31.

Pollack

. Comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder. J Clin Psychiatry 2001;62(suppl 12):24–9.

Culpepper

Generalized anxiety disorder in primary care: Emerging issues in management and treatment. J Clin Psychiatry 2002;63(suppl 8):35–42.

10.

Blomhoff

Haug

Kellstrom

Holme

Humble

Madsbu

, and others. Randomized controlled general practice trial of sertraline, exposure therapy and combined treatment in generalized social phobia. Br J Psychiatry 200;179:23–30.

11.

Stein

Goodwin

Kumar

Hunter

The selective serotonin reuptake inhibitor paroxetine is effective in more generalized and in less generalized social anxiety disorder. Psychopharmacol 2001;158:267–72.

12.

Stein

Pitts

Kumar

Hunter

Predictors of response to pharmacotherapy in social anxiety disorder: An analysis of 3 placebo-controlled paroxetine trials. J Clin Psychiatry 2002;63:152–5.

13.

Randall

Johnson

Thevos

Sonne

Thomas

Willard

, and others. Paroxetine for social anxiety and alcohol use in dual-diagnosed patients. Depress Anxiety 2001;14:255–62.

14.

Liebowitz

Stein

Tancer

Carpenter

Oakes

Pitts

. A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder. J Clin Psychiatry 2002;63:66–74.

15.

Van Ameringen

Mancini

Pharmacotherapy of social anxiety disorder at the turn of the millennium. Psychiatr Clin North Am 2001;24:783–803.

16.

Kobak

Greist

Jefferson

Katzelnick

. Fluoxetine in social phobia: A double-blind, placebo-controlled pilot study. J Clin Psychopharmacol 2002;22:257–62.

17.

Lecrubier

The burden of depression and anxiety in general medicine. J Clin Psychiatry 2001;62(suppl 8):4–9.

18.

Wittchen

Kessler

Beesdo

Drause

Hofler

Howyer

Generalized anxiety and depression in primary care: Prevalence, recognition, and management. J Clin Psychiatry 2002;63(suppl 8):24–34.

19.

Pollack

. Optimizing pharmacotherapy of generalized anxiety to achieve remission. J Clin Psychiatry 2001;62(suppl 19):20–5.

20.

de Graaf

Bijl

Smit

Vollebergh

Spijker

Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: Findings from the Netherlands Mental Health Survey and Incidence Study. Am J Psychiatry 2002;159:620–9.

21.

Zimmerman

Chelminski

McDermut

Major depressive disorder and Axis I diagnostic comorbidity. J Clin Psychiatry 2002;63:187–93.

22.

Kessler

Nelson

McGonagle

Liu

Swartz

Blazer

. Comorbidity of DSM-III-R major depressive disorder in the general population: Results from the US National Comorbidity Survey. Br J Psychiatry 1996;168(suppl 30):17–30.

23.

Melartin

Rytsala

Leskela

Lestela-Mielonen

Sokero

Isometsa

. Current comorbidity of psychiatryric disorders among DSM-IV major depressive disorder patients in psychiatryric care in the Vantaa Depression Study. J Clin Psychiatry 2002;63:126–34.

24.

Rapaport

Prevalence, recognition, and treatment of comorbid depression and anxiety. J Clin Psychiatry 2001;62(suppl 24):6–10.

25.

Petersen

Gordon

Kant

Fava

Rosenbaum

Nierenberg

. Treatment resistant depression and Axis I co-morbidity. Psychol Med 2001;31:1223–9.

26.

Axelson

Birmaher

Relation between anxiety and depressive disorders in childhood and adolescence. Depress Anxiety 2001;14:67–78.

27.

Lenze

Mulsant

Shear

Alexopoulos

Frank

Reynolds

. Comorbidity of depression and anxiety in later life. Depress Anxiety 2001;14:86–93.

28.

Goldstein

. Depression and anxiety in older women. Primary Care: Clinics in Office Practice 2002;29:69–80.

29.

Doraiswamy

. Contemporary management of comorbid anxiety and depression in geriatric patients. J Clin Psychiatry 2001:62(Suppl 12):30–5.

30.

Paykel

. Classification of depressed patients: A cluster analysis derived grouping. Br J Psychiatry 1971;118:275–88.

31.

Stahl

Mixed anxiety and depression: Clinical implications. J Clin Psychiatry 1993;54 Suppl:33–8.

32.

Kendler

Eaves

Walters

Neale

Heath

Kessler

. The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Arch Gen Psychiatry 1996;53:391–9.

33.

Katon

Roy-Byrne

. Mixed anxiety depression. J Abnorm Psychol 1991;100:337–45.

34.

Goldberg

. The management of anxious depression in primary care. J Clin Psychiatry 1999;60:39–42.

35.

Zinbarg

Barlow

Liebowitz

Street

Broadhead

Katon

, and others. The DSM-IV field trial for mixed anxiety–depression. Am J Psychiatry 1994;151:1153–62.

36.

Lydiard

. Anxious depression. J Clin Psychiatry 1998;59(suppl 18):10–7.

37.

World Health Organization. The ICD-10 classification of mental disorders. Clinical descriptions and diagnostic guidelines. Geneva: WHO; 1992.

38.

Clayton

Grove

Coryell

Keller

Hirschfield

Fawcett

Follow-up and family study of anxious depression. Am J Psychiatry 1991;148:1512–7.

39.

Malhi

Parker

Gladstone

Wilhelm

Mitchell

. Recognizing the anxious face of depression. J Nerv Ment Dis 2002;190:366–73.

40.

Ninan

Berger

Symptomatic and syndromal anxiety and depression. Depress Anxiety 2001;14:79–85.

41.

Rampello

Nicoletti

Raffaele

Drago

Comparative effects of amitriptyline and amineptine in patients affected by anxious depression. Neuropsychobiol 1995;31:130–4.

42.

Fawcett

Marcus

Anton

O'Brien

Schwiderski

Response of anxiety and agitation symptoms during nefazodone treatment of major depression. J Clin Psychiatry 1995;56(suppl 6):37–42.

43.

Delini-Stula

Mikkelsen

Angst

Therapeutic efficacy of antidepressants in agitated anxious depression—a meta-analysis of moclobemide studies. J Affect Disord 1995;35:21–30.

44.

Ravindran

Judge

Hunter

Bray

Morton

. A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group. J Clin Psychiatry 1997;58:112–8.

45.

Rudolph

Entsuah

Chitra

A meta-analysis of the effects of venlafaxine on anxiety associated with depression. J Clin Psychopharmacol 1998;18:36–44.

46.

Marchesi

Ceccherininelli

Rossi

Maggini

Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline. Pharmacopsychiatry 1998;31:216–21.

47.

Versiani

Ontiveros

Mazzotti

Ospina

Davila

Mata

, and others. Fluoxetine versus amitriptyline in the treatment of major depression with associated anxiety (anxious depression): A double-blind comparison. Int Clin Psychopharmacol 1999;14:321–7.

48.

Fawcett

Barkin

. A meta-analysis of 8 randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety. J Clin Psychiatry 1998;59:123–7.

49.

Silverstone

PH.

Ravindran

Efficacy and tolerability of once-daily venlafaxine XR vs fluoxetine in depressed outpatients with concomitant anxiety. J Clin Psychiatry 1999;60:22–8.

50.

Fava

Rosenbaum

Hoog

Tepner

Kopp

Nilsson

. Fluoxetine versus sertraline and paroxetine in major depression: Tolerability and efficacy in anxious depression. J. Affect Disord 2000;59:119–26.

51.

Trivedi

Rush

Carmody

Donahue

Bolden-Watson

Houser

, and others. Do bupropion SR and sertraline differ in their effects on anxiety in depressed patients? J Clin Psychiatry 2001;62:776–81.

52.

Davidson

Meoni

Haudiquet

Cantillon

Hackett

Achieving remission with venlafaxine and fluoxetine in major depression: Its relationship to anxiety symptoms. Depress Anxiety 2002;16:4–13.

53.

Spalletta

Pasini

Caltagirone

Fluoxetine alone in the treatment of first episode anxious-depression: An open clinical trial. J Clin Psychopharmacol 2002;22:263–6.

54.

Levine

Cole

Chengappa

KNR

Gershon

Anxiety disorders and major depression, together or apart. Depress Anxiety 2001;14:94–104.